8/13/2015 Cash 0.5 6/30/2015 7/21/2015 8/12/2015
1/8/2015 Cash 0.1 12/4/2014 1/12/2015 1/28/2015
12/24/2013 Cash 0.45 12/5/2013 12/16/2013 12/23/2013
6/5/2013 Cash 1.6 4/23/2013 5/7/2013 6/4/2013
12/6/2012 Cash 2 11/29/2012 12/10/2012 12/21/2012
Read more: http://www.nasdaq.com/symbol/enzn/dividend-history#ixzz3fnq9fLeZ
recurring dividend? "This is great for current shareholders. However, it is impossible to predict when a company will payout a special dividend"..Read more here:
http://www.dividend.com/dividend-education/special-dividends-everything-investors-need-to-know/
The company also mentioned that "We believe that our anticipated royalty revenues, primarily
anticipated royalty revenues from sales of PegIntron, together with our anticipated rental income from our sublease to Axcellerate and our cash
on hand, will be sufficient to fund our operations, at least, through June 30, 2016"
This stock essentially a trust" fund, collecting royalties from Merck.
1/8/2015 Cash 0.1 12/4/2014 1/12/2015 1/28/2015
12/24/2013 Cash 0.45 12/5/2013 12/16/2013 12/23/2013
6/5/2013 Cash 1.6 4/23/2013 5/7/2013 6/4/2013
12/6/2012 Cash 2 11/29/2012 12/10/2012 12/21/2012
Read more: http://www.nasdaq.com/symbol/enzn/dividend-history#ixzz3fnq9fLeZ
recurring dividend? "This is great for current shareholders. However, it is impossible to predict when a company will payout a special dividend"..Read more here:
http://www.dividend.com/dividend-education/special-dividends-everything-investors-need-to-know/
The company also mentioned that "We believe that our anticipated royalty revenues, primarily
anticipated royalty revenues from sales of PegIntron, together with our anticipated rental income from our sublease to Axcellerate and our cash
on hand, will be sufficient to fund our operations, at least, through June 30, 2016"
This stock essentially a trust" fund, collecting royalties from Merck.
My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.
Recent ENZN News
- Form 8-A12G - Registration of securities [Section 12(g)] • Edgar (US Regulatory) • 05/05/2026 08:13:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/05/2026 08:10:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/04/2026 08:16:10 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 12:56:12 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/29/2026 08:57:54 PM
- Enzon Announces Completion of the Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock • GlobeNewswire Inc. • 03/25/2026 12:45:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/25/2026 12:38:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 12:36:13 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 03/25/2026 12:33:16 PM
- Enzon Announces Reverse Stock Split • GlobeNewswire Inc. • 03/24/2026 12:45:00 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 03/24/2026 12:35:53 PM
- Form 8-A12G/A - Registration of securities [Section 12(g)]: [Amend] • Edgar (US Regulatory) • 03/24/2026 12:33:09 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/24/2026 12:30:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 12:30:15 PM
- Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock • GlobeNewswire Inc. • 03/19/2026 08:30:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/19/2026 08:18:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/19/2026 08:16:32 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 03/19/2026 08:07:03 PM
- Form 8-A12G/A - Registration of securities [Section 12(g)]: [Amend] • Edgar (US Regulatory) • 03/18/2026 12:52:08 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/18/2026 12:48:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/18/2026 12:45:26 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/16/2026 08:10:19 PM
- Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock • GlobeNewswire Inc. • 03/16/2026 08:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/16/2026 08:05:43 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 03/16/2026 08:00:54 PM
